Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

2.

The burden of malignant melanoma--lessons to be learned from Austria.

Monshi B, Vujic M, Kivaranovic D, Sesti A, Oberaigner W, Vujic I, Ortiz-Urda S, Posch C, Feichtinger H, Hackl M, Rappersberger K.

Eur J Cancer. 2016 Mar;56:45-53. doi: 10.1016/j.ejca.2015.11.026. Epub 2016 Jan 20.

3.

Evaluation of a mammography screening program within the population-based Vorarlberg Health Monitoring & Prevention Program (VHM&PP).

Nagel G, Oberaigner W, Peter RS, Ulmer H, Concin H.

Cancer Epidemiol. 2015 Dec;39(6):812-8. doi: 10.1016/j.canep.2015.10.001. Epub 2015 Oct 18.

PMID:
26651439
4.

High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing.

Pölsler L, Fiegl H, Wimmer K, Oberaigner W, Amberger A, Traunfellner P, Morscher RJ, Weber I, Fauth C, Wernstedt A, Sperner-Unterweger B, Oberguggenberger A, Hubalek M, Marth C, Zschocke J.

Eur J Hum Genet. 2016 Feb;24(2):258-62. doi: 10.1038/ejhg.2015.108. Epub 2015 May 27.

PMID:
26014432
5.

The ONCOTYROL Prostate Cancer Outcome and Policy Model: Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening.

Mühlberger N, Kurzthaler C, Iskandar R, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U.

Med Decis Making. 2015 Aug;35(6):758-72. doi: 10.1177/0272989X15585114. Epub 2015 May 14.

PMID:
25977360
6.

Dual-energy contrast-enhanced spectral mammography (CESM).

Daniaux M, De Zordo T, Santner W, Amort B, Koppelstätter F, Jaschke W, Dromain C, Oberaigner W, Hubalek M, Marth C.

Arch Gynecol Obstet. 2015 Oct;292(4):739-47. doi: 10.1007/s00404-015-3693-2. Epub 2015 Mar 27.

PMID:
25814297
7.

Liver Transplantation-Associated Lung Cancer: Comparison of Clinical Parameters and Outcomes.

Kocher F, Finkenstedt A, Fiegl M, Graziadei I, Gamerith G, Oberaigner W, Vogel W, Hilbe W.

Clin Lung Cancer. 2015 Sep;16(5):e75-81. doi: 10.1016/j.cllc.2015.02.003. Epub 2015 Feb 17.

PMID:
25783479
8.

Patient-reported urinary incontinence and erectile dysfunction following radical prostatectomy: results from the European Prostate Centre Innsbruck.

Geiger-Gritsch S, Oberaigner W, Mühlberger N, Siebert U, Ladurner M, Klocker H, Horninger W.

Urol Int. 2015;94(4):419-27. doi: 10.1159/000369475. Epub 2015 Jan 31.

PMID:
25662301
9.

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.

Kocher F, Hilbe W, Seeber A, Pircher A, Schmid T, Greil R, Auberger J, Nevinny-Stickel M, Sterlacci W, Tzankov A, Jamnig H, Kohler K, Zabernigg A, Frötscher J, Oberaigner W, Fiegl M.

Lung Cancer. 2015 Feb;87(2):193-200. doi: 10.1016/j.lungcan.2014.12.006. Epub 2014 Dec 18.

PMID:
25564398
10.

Mortality in Parkinson's disease: a 38-year follow-up study.

Pinter B, Diem-Zangerl A, Wenning GK, Scherfler C, Oberaigner W, Seppi K, Poewe W.

Mov Disord. 2015 Feb;30(2):266-9. doi: 10.1002/mds.26060. Epub 2014 Dec 1.

PMID:
25447933
11.

The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening.

Mühlberger N, Heijnsdijk EA, Kurzthaler C, Iskandar R, Krahn MD, Bremner K, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U.

Value Health. 2014 Nov;17(7):A559. doi: 10.1016/j.jval.2014.08.1843. Epub 2014 Oct 26. No abstract available.

12.

Cause-specific mortality in adult epilepsy patients from Tyrol, Austria: hospital-based study.

Granbichler CA, Oberaigner W, Kuchukhidze G, Bauer G, Ndayisaba JP, Seppi K, Trinka E.

J Neurol. 2015 Jan;262(1):126-33. doi: 10.1007/s00415-014-7536-z. Epub 2014 Oct 26.

13.

Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria.

Oberaigner W, Ebenbichler C, Oberaigner K, Juchum M, Schönherr HR, Lechleitner M.

BMC Public Health. 2014 Oct 10;14:1058. doi: 10.1186/1471-2458-14-1058.

14.

Cemented ABG-II prosthesis: 5-year results.

Krismer M, Nogler M, Huber D, Oberaigner W.

Hip Int. 2015 Jan-Feb;25(1):56-60. doi: 10.5301/hipint.5000185. Epub 2014 Sep 1.

PMID:
25198305
15.

Prediction of cancer incidence in Tyrol/Austria for year of diagnosis 2020.

Oberaigner W, Geiger-Gritsch S.

Wien Klin Wochenschr. 2014 Oct;126(19-20):642-9. doi: 10.1007/s00508-014-0596-3. Epub 2014 Sep 6.

PMID:
25193482
16.

Increased suicide risk in cancer patients in Tyrol/Austria.

Oberaigner W, Sperner-Unterweger B, Fiegl M, Geiger-Gritsch S, Haring C.

Gen Hosp Psychiatry. 2014 Sep-Oct;36(5):483-7. doi: 10.1016/j.genhosppsych.2014.05.017. Epub 2014 Jun 2.

PMID:
25015541
17.

Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients.

Fiegl M, Pircher A, Waldthaler C, Gamerith G, Kocher F, Pall G, Nevinny M, Schmid T, Sterlacci W, Jamnig H, Zangerl G, Zabernigg A, Oberaigner W, Hilbe W.

Lung Cancer. 2014 May;84(2):168-74. doi: 10.1016/j.lungcan.2014.02.005. Epub 2014 Feb 17.

PMID:
24646832
18.

Site-specific proportion cured models applied to cancer registry data.

Edlinger M, Ulmer H, Cvancarova M, Oberaigner W.

Cancer Causes Control. 2014 Mar;25(3):365-73. doi: 10.1007/s10552-014-0337-y. Epub 2014 Jan 18.

PMID:
24442714
19.

Perinatal mortality and advanced maternal age.

Mutz-Dehbalaie I, Scheier M, Jerabek-Klestil S, Brantner C, Windbichler GH, Leitner H, Egle D, Ramoni A, Oberaigner W.

Gynecol Obstet Invest. 2014;77(1):50-7. doi: 10.1159/000357168. Epub 2013 Dec 19.

20.

Migrants and obstetrics in Austria--applying a new questionnaire shows differences in obstetric care and outcome.

Oberaigner W, Leitner H, Oberaigner K, Marth C, Pinzger G, Concin H, Steiner H, Hofmann H, Wagner T, Mörtl M, Ramoni A.

Wien Klin Wochenschr. 2013 Jan;125(1-2):34-40. doi: 10.1007/s00508-012-0312-0. Epub 2013 Jan 5.

PMID:
23292644
Items per page

Supplemental Content

Loading ...
Write to the Help Desk